Wang et al. suggest the use of MYBL1 as an immunotherapy biomarker in clear cell renal cell carcinoma [11], and our data show that some TNBCs express high levels of the MYBL1 gene [12]. The gene discussed is MYBL1; the disease is clear cell renal carcinoma.